Carl Icahn
Carl Icahn's Portfolio
| Ticker | # of Shares | Price | Value | |
|---|---|---|---|---|
| CVI | 71,198,718 | $66.44 | $4,730,442,824 | |
| CHK | 59,698,689 | $21.48 | $1,282,327,840 | |
| NFLX | 5,541,066 | $225.58 | $1,249,953,669 | |
| FRX | 30,662,005 | $38.85 | $1,191,218,895 | |
| RIG | 20,154,035 | $51.42 | $1,036,320,480 | |
| HLF | 16,966,485 | $47.77 | $810,488,989 | |
| HLF | 16,355,131 | $47.77 | $781,284,608 | |
| FDML | 76,697,804 | $9.37 | $718,658,424 | |
| NUAN | 33,899,274 | $19.20 | $650,866,061 | |
| HAIN | 7,239,963 | $68.54 | $496,227,065 | |
| View Additional Portfolio Information » | ||||
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
-
Herbalife (HLF) Hires New Auditor to Ackman's Chagrin
-
Investors Brace for Epic Herbalife (HLF) Short Squeeze
-
The Hispanic Community is Not Happy with Herbalife (HLF)
-
Carl Icahn's Q1 13F Reveals Little New
-
Third Point's Loeb Said to Joke About Ackman's Research on Herbalife (HLF)
-
Herbalife (HLF) on Watch Ahead of Bill Ackman Ira Sohn Presentation
-
Market Wrap: Einhorn Sees Green in Apple; Disney's Magical Quarter; JCPenney Sales Slip
-
Carl Icahn Raises Stake in Herbalife (HLF) to 16.48%
-
Form SC 13D/A HERBALIFE LTD. Filed by: ICAHN CARL C
-
Form 4 HERBALIFE LTD. For: May 03 Filed by: ICAHN CARL C
-
Two Icahn Nominees Quietly Added to Herbalife (HLF) Board; No New Auditor Named
-
Herbalife Announces Results of 2013 Annual Meeting of Shareholders
-
Herbalife's (HLF) Fate Continues to Be Dominated by Outside Forces
-
Neither Bill Ackman or Carl Icahn Involved in Insider Trading on Herbalife (HLF)
-
Herbalife (HLF) Auditor Resigns After Providing Insider Information
-
Buy Herbalife! Ackman's Foresight Under Fire Following JCPenney (JCP) Shakeup
-
Ackman Says Herbalife (HLF) Was First Case of 'Sniping' Among Fund Managers
-
Herbalife (HLF) CEO Johnson Receives 'Max Compensation' in FY12
-
Pershing Square Claws for 6% Gain in Q1
-
Tough Pill to Swallow: Icahn Up Slightly on Herbalife (HLF) Amid $600M+ Bet
-
Herbalife (HLF) Brushes Off Latest Ack-Attack as 'Nothing New'
-
Market Wrap: New Pope Elected; Dow Streak Hits 9, S&P is Next; A BlackBerry Surprise!
-
Short Seller Sues Banks, Icahn Over Support of Herbalife (HLF) (BAC) (JPM)
-
Ackman Breathes Easier as Major Consumer Group Calls for FTC Investigation of Herbalife (HLF)
-
Icahn Continues Loading Up on Shares of Herbalife (HLF)
-
Top 10 News Items for 03/04 to 03/08: Dow Jones Reaches New Heights; Jobs, Jobs, Jobs; Icahn's Making Moves
-
StreetInsider.com Pre-Open Movers 03/08: (P) (AMBA) (TPX) Higher; (SKUL) (MXWL) (MED) Lower (more...)
-
Streetinsider.com After-Hours Movers 3/7: (P) (HRB) (C) Higher; (MED) (ZQK) (AVG) Lower (more...)
-
Carl Icahn Raises Stake in Herbalife (HLF) to 15.55%
-
It's a Carl Icahn Market
-
Herbalife (HLF) Director Accuses Ackman of 'Throwing Rocks' to Support Short
-
Netflix (NFLX) Under Heavy Pressure; Icahn Selling Rumors Resurface
-
Icahn Receives Early HSR Termination from FTC on Herbalife (HLF) Deal
-
Top 10 News Items for 02/25 - 03/01: Investors Love/Hate Groupon; Best Buy Not Bought; Icahn Becomes Vitamin Salesman
-
Streetinsider.com's Hot Lunchtime Reads 03/01: (ISRG) (BBY) (AAPL) (HLF) (GRPN)
-
Icahn Adds Up $230M to War Chest to Squeeze Ackman's Brains Out in Herbalife (HLF)
-
Market Wrap: Icahn Moves on Herbalife; Groupon CEO Gets Discounted; Senate Votes on Sequester
-
Icahn Files Support Agreement for Herbalife (HLF)
-
Carl Icahn Discusses Herbalife (HLF) Director Deal and Bashes Ackman
-
Icahn Wants to Buy More Herbalife (HLF), Doesn't Share Same Criticisms as Ackman
-
Herbalife (HLF) to Nominate Two Icahn Reps to Board
-
Pershing Square's Ackman Caught Between Rock and Hard Place (HLF) (JCP)
-
Herbalife (NYSE: HLF) says it has nothing to report on Icahn
-
Loeb Sells Portion of Herbalife (HLF) Position, But Still Maintains Stake
-
Top 10 News Items for 02/11 - 02/15: Once-in-a-Millennium Papal Event; Buffett's Big Buy; Comcast Takes All of NBCU
-
Carl Icahn Plans to Exercise Option Position in Herbalife (HLF)
-
Icahn said didn't buy Herbalife (HLF) to 'get even' with Ackman
-
Streetinsider.com's Hot Lunchtime Reads 02/15: (CHK) (HLF) (SPWR) (MWV)
-
Icahn says the way to short stocks is to keep quiet
-
Herbalife (HLF) Moves Off Highs with Icahn Interview Ongoing
